Gut bacteria selectively promoted by dietary fibers alleviate type 2 diabetes
The DOI matches its Crossref record; 62 of the 63 references it cites were found in a registry or an index.
Abstract
Microbial modulation of diabetes: Short-chain fatty acids (SCFAs) are produced by various human gut microbes. SCFAs act as an energy source to the colonic epithelium and are also sensed by host signaling pathways that modulate appetite and inflammation. Deficiency of gut SCFAs is associated with type 2 diabetes. Zhao et al. found that adopting a high-fiber diet promoted the growth of SCFA-producing organisms in diabetic humans. The high-fiber diet induced changes in the entire gut microbe community and correlated with elevated levels of glucagon-like peptide-1, a decline in acetylated hemoglobin levels, and improved blood-glucose regulation. Science , this issue p. 1151
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, gut bacteria respond to a high-fiber diet as guilds rather than taxa, suggesting that guilds may mediate the beneficial effects of dietary fiber on immunotherapy.152”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [152]
In the citing paper
“Indeed, gut bacteria respond to a high-fiber diet as guilds rather than taxa, suggesting that guilds may mediate the beneficial effects of dietary fiber on immunotherapy.152”
From Melanoma and microbiota: Current understanding and future directions (2024) · cites this paper as [152]
In the citing paper
“A lower abundance of SCFA-producing bacteria has been associated with higher risk of type 2 diabetes.89”
From Influence of the Gut Microbiome, Diet, and Environment on Risk of Colorectal Cancer (2020) · cites this paper as [89]
Citations
Cites
Controlling the False Discovery Rate: A Practical and Powerful Approach to Multiple Testing
Benjamini, Y., & Hochberg, Y. (1995) · Journal of the Royal Statistical Society Series B: Statistical Methodology · doi:10.1111/j.2517-6161.1995.tb02031.x · Cited by 109,482
The Sequence Alignment/Map format and SAMtools
Li, H., Handsaker, B., Wysoker, A., Fennell, T., Ruan, J., Homer, N., Marth, G., Abecasis, G., Durbin, R., & 1000 Genome Project Data Processing Subgroup (2009) · Bioinformatics · doi:10.1093/bioinformatics/btp352 · Cited by 62,041
Fast gapped-read alignment with Bowtie 2
Langmead, B., & Salzberg, S. L. (2012) · Nature Methods · doi:10.1038/nmeth.1923 · Cited by 56,400
QIIME allows analysis of high-throughput community sequencing data
Caporaso, J. G., Kuczynski, J., Stombaugh, J., Bittinger, K., Bushman, F. D., Costello, E. K., Fierer, N., Peña, A. G., Goodrich, J. K., Gordon, J. I., et al. (2010) · Nature Methods · doi:10.1038/nmeth.f.303 · Cited by 34,887
Metagenomic biomarker discovery and explanation
Segata, N., Izard, J., Waldron, L., Gevers, D., Miropolsky, L., Garrett, W. S., & Huttenhower, C. (2011) · Genome Biology · doi:10.1186/gb-2011-12-6-r60 · Cited by 16,192
Prodigal: prokaryotic gene recognition and translation initiation site identification
Hyatt, D., Chen, G.-L., LoCascio, P. F., Land, M. L., Larimer, F. W., & Hauser, L. J. (2010) · BMC Bioinformatics · doi:10.1186/1471-2105-11-119 · Cited by 12,587
Parks, D. H., Imelfort, M., Skennerton, C. T., Hugenholtz, P., & Tyson, G. W. (2015) · Genome Research · doi:10.1101/gr.186072.114 · Cited by 12,496
Velvet: Algorithms for de novo short read assembly using de Bruijn graphs
Zerbino, D. R., & Birney, E. (2008) · Genome Research · doi:10.1101/gr.074492.107 · Cited by 9,491
From Dietary Fiber to Host Physiology: Short-Chain Fatty Acids as Key Bacterial Metabolites
Koh, A., De Vadder, F., Kovatcheva-Datchary, P., & Bäckhed, F. (2016) · Cell · doi:10.1016/j.cell.2016.05.041 · Cited by 7,070
A metagenome-wide association study of gut microbiota in type 2 diabetes
Qin, J., Li, Y., Cai, Z., Li, S., Zhu, J., Zhang, F., Liang, S., Zhang, W., Guan, Y., Shen, D., et al. (2012) · Nature · doi:10.1038/nature11450 · Cited by 6,762
Self-citation
Research works printed but not linked: 3
- Chinese Diabetes Society, China guideline for type 2 diabetes (2013 edition). Chin. J. Diabetes Mellitus 6, 447–498 (2014).
- Y. Yang G. Wang X. Pan China Food Composition (Book 1 Beijing Medical Univ. Press ed. 2 2009).
- H. Wu, R. Wang, Y. Zhao, X. Pang, J. Shen, C. Zhang, ., Exploring carbohydrate utilization capacity of Bifidobacterium pseudocatenulatum isolated from a morbidly obese child after dietary intervention. Genomics Appl. Biol. 34, 1384–1391 (2015).
Cited by
Items 101–200 of 1,011
Molecular link between dietary fibre, gut microbiota and health
Kumar, J., Rani, K., & Datt, C. (2020) · Molecular Biology Reports · doi:10.1007/s11033-020-05611-3 · Cited by 192
Tanase, D. M., Gosav, E. M., Neculae, E., Costea, C. F., Ciocoiu, M., Hurjui, L. L., Tarniceriu, C. C., Maranduca, M. A., Lacatusu, C. M., Floria, M., et al. (2020) · Nutrients · doi:10.3390/nu12123719 · Cited by 207
“[42] demonstrated that a GM that is selectively sustained by high-dietary fibers led to increased butyrate- and acetate-producing microbiome products, improved glucose intolerance, lowered hemoglobin A1c levels and overall alleviated T2DM.”
BackgroundSong, X., Zhong, L., Lyu, N., Liu, F., Li, B., Hao, Y., Xue, Y., Li, J., Feng, Y., Ma, Y., et al. (2019) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2019.03.001 · Cited by 208
“Genetically obese mice and lean mice have marked differences in several metabolic parameters and the gut microbiota [4].”
Nie, Q., Chen, H., Hu, J., Fan, S., & Nie, S. (2019) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2018.1536646 · Cited by 204
“…trial found that the supplementation with dietary fiber (rich in polysaccharide) increased the abundance of SCFA- producing bacteria, which in turn normalized the levels of HbA1c via an increase in the production of glucagon-like peptide- 1 (GLP-1) in patients with T2D (Zhao et al. 2018).”
BackgroundInfluentialThe Dynamic Interplay between the Gut Microbiota and Autoimmune Diseases
Xu, H., Liu, M., Cao, J., Li, X., Fan, D., Xia, Y., Lu, X., Li, J., Ju, D., & Zhao, H. (2019) · Journal of Immunology Research · doi:10.1155/2019/7546047 · Cited by 194
“The diverse human gut microbiota plays a fundamental role in the well-being of hosts and is closely correlated with the growth, development, substance metabolism, and immune function of the host [31].”
BackgroundPirih, F. Q., Monajemzadeh, S., Singh, N., Sinacola, R. S., Shin, J. M., Chen, T., Fenno, J. C., Kamarajan, P., Rickard, A. H., Travan, S., et al. (2021) · Periodontology 2000 · doi:10.1111/prd.12379 · Cited by 197
Guild-based analysis for understanding gut microbiome in human health and diseases
Wu, G., Zhao, N., Zhang, C., Lam, Y. Y., & Zhao, L. (2021) · Genome Medicine · doi:10.1186/s13073-021-00840-y · Cited by 203
“For example, in our study of patients with type 2 diabetes [41], a high-fiber dietary intervention increased the gut microbial community’s capacity to produce butyrate, as evidenced by significantly higher fecal content of butyrate after 28 days of intervention.”
BackgroundSelf-citationInulin supplementation ameliorates hyperuricemia and modulates gut microbiota in Uox-knockout mice
Guo, Y., Yu, Y., Li, H., Ding, X., Li, X., Jing, X., Chen, J., Liu, G., Lin, Y., Jiang, C., et al. (2021) · European Journal of Nutrition · doi:10.1007/s00394-020-02414-x · Cited by 200
Self-citationMicrobial enterotypes in personalized nutrition and obesity management
Christensen, L., Roager, H. M., Astrup, A., & Hjorth, M. F. (2018) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqy175 · Cited by 190
Hiel, S., Bindels, L. B., Pachikian, B. D., Kalala, G., Broers, V., Zamariola, G., Chang, B. P. I., Kambashi, B., Rodriguez, J., Cani, P. D., et al. (2019) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqz001 · Cited by 197
“Interestingly, a recent study showed that prebiotic supplementation in individuals with type 2 diabetes mellitus decreases gene richness in addition to a significant clinical improvement (42).”
BackgroundO'Keefe, S. J. (2019) · The Lancet Gastroenterology & Hepatology · doi:10.1016/s2468-1253(19)30257-2 · Cited by 186
Jardon, K. M., Canfora, E. E., Goossens, G. H., & Blaak, E. E. (2022) · Gut · doi:10.1136/gutjnl-2020-323715 · Cited by 181
Zhou, Z.-L., Jia, X.-B., Sun, M.-F., Zhu, Y.-L., Qiao, C.-M., Zhang, B.-P., Zhao, L.-P., Yang, Q., Cui, C., Chen, X., et al. (2019) · Neurotherapeutics · doi:10.1007/s13311-019-00719-2 · Cited by 195
Self-citationDeciphering the Chemical Lexicon of Host–Gut Microbiota Interactions
Nicolas, G. R., & Chang, P. V. (2019) · Trends in Pharmacological Sciences · doi:10.1016/j.tips.2019.04.006 · Cited by 195
“Increased acetate and butyrate levels also result in increased anorectic hormones, such as glucagon-like peptide-1 (GLP-1) and fasting peptide YY (PYY), a peptide hormone that reduces appetite, and alleviates T2D in humans [29].”
BackgroundEpigenetic Regulation at the Interplay Between Gut Microbiota and Host Metabolism
Miro-Blanch, J., & Yanes, O. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00638 · Cited by 195
Palmnäs-Bédard, M. S., Costabile, G., Vetrani, C., Åberg, S., Hjalmarsson, Y., Dicksved, J., Riccardi, G., & Landberg, R. (2022) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqac217 · Cited by 185
SUN, S.-S., WANG, K., MA, K., BAO, L., & LIU, H.-W. (2019) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(19)30003-2 · Cited by 194
Nguyen, N. K., Deehan, E. C., Zhang, Z., Jin, M., Baskota, N., Perez-Muñoz, M. E., Cole, J., Tuncil, Y. E., Seethaler, B., Wang, T., et al. (2020) · Microbiome · doi:10.1186/s40168-020-00887-w · Cited by 189
“These compositional variations likely determine both the competitive and cooperative relationships between community members that form trophic networks, some of which organize into ecological “guilds” that collaborate to degrade complex fibers [20].”
BackgroundMethodDiet-gut microbiota-epigenetics in metabolic diseases: From mechanisms to therapeutics
Li, D., Li, Y., Yang, S., Lu, J., Jin, X., & Wu, M. (2022) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2022.113290 · Cited by 182
Immunomodulatory effects of inulin and its intestinal metabolites
Sheng, W., Ji, G., & Zhang, L. (2023) · Frontiers in Immunology · doi:10.3389/fimmu.2023.1224092 · Cited by 170
“demonstrated that inulin-induced SCFAs interact with FFARs expressed on L cells, promoting the secretion of intestinal peptides (including GLP-1 and fasting peptide YY (PYY)), thereby improving glucose metabolism and insulin resistance (112, 113).”
BackgroundBee Pollen as Functional Food: Insights into Its Composition and Therapeutic Properties
Ghouizi, A. E., Bakour, M., Laaroussi, H., Ousaaid, D., Menyiy, N. E., Hano, C., & Lyoussi, B. (2023) · Antioxidants · doi:10.3390/antiox12030557 · Cited by 206
Quorum sensing for population-level control of bacteria and potential therapeutic applications
Wu, S., Liu, J., Liu, C., Yang, A., & Qiao, J. (2020) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-019-03326-8 · Cited by 189
Gut microbiota and diabetes: From correlation to causality and mechanism
Li, W.-Z., Stirling, K., Yang, J.-J., & Zhang, L. (2020) · World Journal of Diabetes · doi:10.4239/wjd.v11.i7.293 · Cited by 185
Short-chain fatty acid, acylation and cardiovascular diseases
Chen, X.-F., Chen, X., & Tang, X. (2020) · Clinical Science · doi:10.1042/cs20200128 · Cited by 183
Impact of food additives on the composition and function of gut microbiota: A review
Cao, Y., Liu, H., Qin, N., Ren, X., Zhu, B., & Xia, X. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.03.006 · Cited by 173
Huang, S., Chen, J., Cui, Z., Ma, K., Wu, D., Luo, J., Li, F., Xiong, W., Rao, S., Xiang, Q., et al. (2023) · Science Advances · doi:10.1126/sciadv.adi7337 · Cited by 177
“In human studies, HFDFs were shown to improve insulin sensitivity and reduce the risk of diabetes because of their protective effects on gut homeostasis and chronic inflammation ( 13 ).”
Utilization of the microbiome in personalized medicine
Ratiner, K., Ciocan, D., Abdeen, S. K., & Elinav, E. (2024) · Nature Reviews Microbiology · doi:10.1038/s41579-023-00998-9 · Cited by 170
“This increase in SCFA-producing bacteria coincided with an improvement in HbA1c levels (a marker of glycaemic control) attributed to the enhanced GLP-1 production 152 (Fig.”
Gut microbiota: A new target for T2DM prevention and treatment
Liu, L., Zhang, J., Cheng, Y., Zhu, M., Xiao, Z., Ruan, G., & Wei, Y. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.958218 · Cited by 176
“In T2DM patients, reduced SCFA levels caused by decreased abundance of SCFA-producing bacteria may contribute to the progression of IR and T2DM (31).”
BackgroundDysbiosis and Implication of the Gut Microbiota in Diabetic Retinopathy
Huang, Y., Wang, Z., Ma, H., Ji, S., Chen, Z., Cui, Z., Chen, J., & Tang, S. (2021) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2021.646348 · Cited by 180
“Previous studies reported that SCFAs could improve glucose homeostasis and were associated with reduced risk of T2DM, obesity, and cardiovascular disease (Chambers et al., 2018; Zhao et al., 2018).”
BackgroundDepletion of microbiome-derived molecules in the host using Clostridium genetics
Guo, C.-J., Allen, B. M., Hiam, K. J., Dodd, D., Van Treuren, W., Higginbottom, S., Nagashima, K., Fischer, C. R., Sonnenburg, J. L., Spitzer, M. H., et al. (2019) · Science · doi:10.1126/science.aav1282 · Cited by 173
Liao, B., Qiao, J., & Pang, Y. (2021) · Frontiers in Endocrinology · doi:10.3389/fendo.2021.667422 · Cited by 168
“High-fiber diet elevated GLP-1 levels in patients with type 2 diabetes via promoting the growth of SCFA-producing gut microbiota, and finally improved glucose regulation (89).”
BackgroundParabacteroides distasonis ameliorates insulin resistance via activation of intestinal GPR109a
Sun, Y., Nie, Q., Zhang, S., He, H., Zuo, S., Chen, C., Yang, J., Chen, H., Hu, J., Li, S., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-43622-3 · Cited by 162
Targeting the gut microbiota and its metabolites for type 2 diabetes mellitus
Wu, J., Yang, K., Fan, H., Wei, M., & Xiong, Q. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1114424 · Cited by 203
Zhou, X., Shen, X., Johnson, J. S., Spakowicz, D. J., Agnello, M., Zhou, W., Avina, M., Honkala, A., Chleilat, F., Chen, S. J., et al. (2024) · Cell Host & Microbe · doi:10.1016/j.chom.2024.02.012 · Cited by 167
Gao, H., Wen, J.-J., Hu, J.-L., Nie, Q.-X., Chen, H.-H., Xiong, T., Nie, S.-P., & Xie, M.-Y. (2018) · Carbohydrate Polymers · doi:10.1016/j.carbpol.2018.08.075 · Cited by 168
Microbial catabolism of Porphyra haitanensis polysaccharides by human gut microbiota
Xu, S.-Y., Aweya, J. J., Li, N., Deng, R.-Y., Chen, W.-Y., Tang, J., & Cheong, K.-L. (2019) · Food Chemistry · doi:10.1016/j.foodchem.2019.03.050 · Cited by 170
Self-citationOliver, A., Chase, A. B., Weihe, C., Orchanian, S. B., Riedel, S. F., Hendrickson, C. L., Lay, M., Sewall, J. M., Martiny, J. B. H., & Whiteson, K. (2021) · mSystems · doi:10.1128/msystems.00115-21 · Cited by 171
Mao, T., Huang, F., Zhu, X., Wei, D., & Chen, L. (2021) · Journal of Functional Foods · doi:10.1016/j.jff.2021.104500 · Cited by 216
Self-citationMicrobiota-Centered Interventions: The Next Breakthrough in Immuno-Oncology?
Derosa, L., Routy, B., Desilets, A., Daillère, R., Terrisse, S., Kroemer, G., & Zitvogel, L. (2021) · Cancer Discovery · doi:10.1158/2159-8290.cd-21-0236 · Cited by 170
Li, L., Yao, H., Li, X., Zhang, Q., Wu, X., Wong, T., Zheng, H., Fung, H., Yang, B., Ma, D., et al. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b01489 · Cited by 168
Self-citationNatural polysaccharides exhibit anti-tumor activity by targeting gut microbiota
Liu, L., Li, M., Yu, M., Shen, M., Wang, Q., Yu, Y., & Xie, J. (2019) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2018.10.083 · Cited by 169
Health promoting microbial metabolites produced by gut microbiota after prebiotics metabolism
Peredo-Lovillo, A., Romero-Luna, H. E., & Jiménez-Fernández, M. (2020) · Food Research International · doi:10.1016/j.foodres.2020.109473 · Cited by 167
Seaweed Components as Potential Modulators of the Gut Microbiota
Shannon, E., Conlon, M., & Hayes, M. (2021) · Marine Drugs · doi:10.3390/md19070358 · Cited by 157
Resistant starch, microbiome, and precision modulation
Dobranowski, P. A., & Stintzi, A. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1926842 · Cited by 159
Luo, A., Xie, Z., Wang, Y., Wang, X., Li, S., Yan, J., Zhan, G., Zhou, Z., Zhao, Y., & Li, S. (2022) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2022.104642 · Cited by 162
Self-citationChen, R., Wu, P., Cai, Z., Fang, Y., Zhou, H., Lasanajak, Y., Tang, L., Ye, L., Hou, C., & Zhao, J. (2019) · The Journal of Nutritional Biochemistry · doi:10.1016/j.jnutbio.2018.12.004 · Cited by 169
Gut microbiome-Mediterranean diet interactions in improving host health
Nagpal, R., Shively, C. A., Register, T. C., Craft, S., & Yadav, H. (2019) · F1000Research · doi:10.12688/f1000research.18992.1 · Cited by 164
Li, H., Fang, Q., Nie, Q., Hu, J., Yang, C., Huang, T., Li, H., & Nie, S. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c01968 · Cited by 163
Wu, Z., Zhang, B., Chen, F., Xia, R., Zhu, D., Chen, B., Lin, A., Zheng, C., Hou, D., Li, X., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.1089991 · Cited by 158
“Recent research showed that intestinal dysbiosis is a key factor in the development of metabolic endotoxemia and T2DM (Zhao et al., 2018; Thingholm et al., 2019; Wu et al., 2022).”
BackgroundDi Ciaula, A., Baj, J., Garruti, G., Celano, G., De Angelis, M., Wang, H. H., Di Palo, D. M., Bonfrate, L., Wang, D. Q.-H., & Portincasa, P. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9082648 · Cited by 163
Zhang, H.-Y., Tian, J.-X., Lian, F.-M., Li, M., Liu, W.-K., Zhen, Z., Liao, J.-Q., & Tong, X.-L. (2021) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110857 · Cited by 161
Prebiotics and the Human Gut Microbiota: From Breakdown Mechanisms to the Impact on Metabolic Health
Bedu-Ferrari, C., Biscarrat, P., Langella, P., & Cherbuy, C. (2022) · Nutrients · doi:10.3390/nu14102096 · Cited by 183
van Deuren, T., Blaak, E. E., & Canfora, E. E. (2022) · Obesity Reviews · doi:10.1111/obr.13498 · Cited by 181
Samborska, K., Boostani, S., Geranpour, M., Hosseini, H., Dima, C. V., Khoshnoudi‐Nia, S., Rostamabadi, H., Falsafi, S. R., Shaddel, R., Akbari‐Alavijeh, S., et al. (2021) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2021.01.008 · Cited by 166
Pursuing Human-Relevant Gut Microbiota-Immune Interactions
Spencer, S. P., Fragiadakis, G. K., & Sonnenburg, J. L. (2019) · Immunity · doi:10.1016/j.immuni.2019.08.002 · Cited by 161
“Several longitudinal dietary intervention studies point to the power of diet for altering the microbiota as well as host health(Cotillard et al., 2013; Lewis et al., 2017; Zeevi et al., 2015; Zhao et al., 2018).”
BackgroundDietary Fiber-Induced Microbial Short Chain Fatty Acids Suppress ILC2-Dependent Airway Inflammation
Lewis, G., Wang, B., Shafiei Jahani, P., Hurrell, B. P., Banie, H., Aleman Muench, G. R., Maazi, H., Helou, D. G., Howard, E., Galle-Treger, L., et al. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.02051 · Cited by 163
“and humans increasing Fiber consumption correlated decreased risk of Type II diabetes (47).”
BackgroundRodrigues, R. R., Gurung, M., Li, Z., García-Jaramillo, M., Greer, R., Gaulke, C., Bauchinger, F., You, H., Pederson, J. W., Vasquez-Perez, S., et al. (2021) · Nature Communications · doi:10.1038/s41467-020-20313-x · Cited by 160
Holo-Omics: Integrated Host-Microbiota Multi-omics for Basic and Applied Biological Research
Nyholm, L., Koziol, A., Marcos, S., Botnen, A. B., Aizpurua, O., Gopalakrishnan, S., Limborg, M. T., Gilbert, M. T. P., & Alberdi, A. (2020) · iScience · doi:10.1016/j.isci.2020.101414 · Cited by 177
Effects of dietary fibre on metabolic health and obesity
Deehan, E. C., Mocanu, V., & Madsen, K. L. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00891-z · Cited by 190
“Although many of these metabolites benefit the host, others are considered toxic and detrimental to metabolic health 49,54,63–66 .”
Zhang, X., Zhang, M., Dong, L., Jia, X., Liu, L., Ma, Y., Huang, F., & Zhang, R. (2019) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.9b06477 · Cited by 161
Self-citationGu, W., Wang, Y., Zeng, L., Dong, J.-C., Bi, Q., Yang, X., Che, Y., He, S., & Yu, J. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.109910 · Cited by 165
Microbiome therapeutics: exploring the present scenario and challenges
Yadav, M., & Chauhan, N. S. (2021) · Gastroenterology report · doi:10.1093/gastro/goab046 · Cited by 181
“Diet modification along with other therapy for diabetes improves the glycemic index [191].”
Jiang, Z., Zhuo, L., He, Y., Fu, Y., Shen, L., Xu, F., Gou, W., Miao, Z., Shuai, M., Liang, Y., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30712-x · Cited by 168
Self-citationXu, X., Gao, Z., Yang, F., Yang, Y., Chen, L., Han, L., Zhao, N., Xu, J., Wang, X., Ma, Y., et al. (2020) · Genomics, Proteomics & Bioinformatics · doi:10.1016/j.gpb.2019.09.007 · Cited by 156
“Recent studies have shown that gut microbiota plays an increasingly important role in the development and treatment of T2DM [4,11,15,17,36–38].”
Self-citationSmith, B. J., Miller, R. A., & Schmidt, T. M. (2021) · mSphere · doi:10.1128/msphere.00851-21 · Cited by 170
Chen, L., Liu, B., Ren, L., Du, H., Fei, C., Qian, C., Li, B., Zhang, R., Liu, H., Li, Z., et al. (2023) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2023.1069954 · Cited by 155
“By modulating the structure of gut microbiota, a specially designed high-fiber diet was proved to be able to provide obvious beneficial effects for patients with T2DM (Zhao et al., 2018).”
BackgroundLi, X., Su, C., Jiang, Z., Yang, Y., Zhang, Y., Yang, M., Zhang, X., Du, Y., Zhang, J., Wang, L., et al. (2021) · npj Biofilms and Microbiomes · doi:10.1038/s41522-021-00205-8 · Cited by 148
Self-citationEmerging concepts in intestinal immune control of obesity-related metabolic disease
Khan, S., Luck, H., Winer, S., & Winer, D. A. (2021) · Nature Communications · doi:10.1038/s41467-021-22727-7 · Cited by 149
Gheorghe, C. E., Ritz, N. L., Martin, J. A., Wardill, H. R., Cryan, J. F., & Clarke, G. (2021) · Gut Microbes · doi:10.1080/19490976.2021.1941711 · Cited by 148
The gut microbiome connects nutrition and human health
Sanz, Y., Cryan, J. F., Deschasaux, M., Elinav, E., Lambrecht, R., & Veiga, P. (2025) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-025-01077-5 · Cited by 186
“Higher intakes (35–50 g/day) that would more closely align with prehistorical fibre intake estimates 210 could be required for achieving higher protection against NCDs, such as cardiometabolic and chronic inflammatory conditions such as cancer, through gut microbiome-mediated effects 143,211 .”
Han, Q., Wang, J., Li, W., Chen, Z., & Du, Y. (2021) · Microbiome · doi:10.1186/s40168-021-01046-5 · Cited by 161
“The microbial communities in individuals with obesity, T2DM and CVD were distinct from healthy counterparts [10–12].”
BackgroundInfluentialSelf-citationFougerat, A., Montagner, A., Loiseau, N., Guillou, H., & Wahli, W. (2020) · Cells · doi:10.3390/cells9071638 · Cited by 157
Gut microbiota remodeling: A promising therapeutic strategy to confront hyperuricemia and gout
Wang, Z., Li, Y., Liao, W., Huang, J., Liu, Y., Li, Z., & Tang, J. (2022) · Frontiers in Cellular and Infection Microbiology · doi:10.3389/fcimb.2022.935723 · Cited by 180
“Adding dietary fiber to the diet can significantly change the diversity of gut microbes and increase the abundance of SCFA-producing flora (So et al., 2018; Zhao and Zhang, 2018; Dalile et al., 2019).”
BackgroundYan, J., Pan, Y., Shao, W., Wang, C., Wang, R., He, Y., Zhang, M., Wang, Y., Li, T., Wang, Z., et al. (2022) · Microbiome · doi:10.1186/s40168-022-01390-0 · Cited by 160
“Diets change the intestinal microbiota, which responds differently to diverse dietary structures [43, 45].”
BackgroundSelf-citationZhang, Q., Jin, H., Feng, J., Hu, X., Wang, T., Gong, W., Huang, K. L., Guo, Y., Zou, Z., Xian, L., et al. (2020) · Genome biology · doi:10.1186/s13059-020-02007-1 · Cited by 163
“central to human health and disease [1, 2].”
Self-citationLi, C., Niu, Z., Zou, M., Liu, S., Wang, M., Gu, X., Lu, H., Tian, H., & Jha, R. (2020) · Journal of Dairy Science · doi:10.3168/jds.2019-18003 · Cited by 165
“Similarly, Zhao et al. (2018) proposed the use of prebiotics that increase short-chain fatty acid production to prevent potential diseases associated with intestinal dysbiosis.”
BackgroundStrain-level epidemiology of microbial communities and the human microbiome
Yan, Y., Nguyen, L. H., Franzosa, E. A., & Huttenhower, C. (2020) · Genome Medicine · doi:10.1186/s13073-020-00765-y · Cited by 165
Dietary betaine prevents obesity through gut microbiota-drived microRNA-378a family
Du, J., Zhang, P., Luo, J., Shen, L., Zhang, S., Gu, H., He, J., Wang, L., Zhao, X., Gan, M., et al. (2021) · Gut Microbes · doi:10.1080/19490976.2020.1862612 · Cited by 167
“In contrast, deficiency of SCFAs is positively associated with the development of T2DM, increased adiposity, and obesity.(36) In our model, we identified abundant SCFA-producing bacterial genera in intestinal tract of HFD+B-fed mice or obese mice receiving feces from HFD+B-fed mice.”
BackgroundSelf-citationRoles and Mechanisms of Gut Microbiota in Patients With Alzheimer’s Disease
Wu, S., Liu, X., Jiang, R., Yan, X., & Ling, Z. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.650047 · Cited by 143
Manzoor, M., Singh, J., Bandral, J. D., Gani, A., & Shams, R. (2020) · International Journal of Biological Macromolecules · doi:10.1016/j.ijbiomac.2020.09.182 · Cited by 156
Unravelling the involvement of gut microbiota in type 2 diabetes mellitus
Arora, A., Behl, T., Sehgal, A., Singh, S., Sharma, N., Bhatia, S., Sobarzo‐Sánchez, E., & BUNGAU, S. G. (2021) · Life Sciences · doi:10.1016/j.lfs.2021.119311 · Cited by 158
The Gut Microbiome of Heart Failure With Preserved Ejection Fraction
Beale, A. L., O’Donnell, J. A., Nakai, M. E., Nanayakkara, S., Vizi, D., Carter, K., Dean, E., Ribeiro, R. V., Yiallourou, S. R., Carrington, M. J., et al. (2021) · Journal of the American Heart Association · doi:10.1161/jaha.120.020654 · Cited by 165
“…promotes this process at multiple stages: contribution to obesity and insulin resistance, 29 diabetes mellitus with impacts on diabetic control, 30 interplay with physical inactivity, 31 and aforementioned roles in hypertension 8,9 ; increased levels of regulatory T cells with fiber and SCFA…”
Food Design To Feed the Human Gut Microbiota
Ercolini, D., & Fogliano, V. (2018) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.8b00456 · Cited by 146
Palacios, T., Vitetta, L., Coulson, S., Madigan, C. D., Lam, Y. Y., Manuel, R., Briskey, D. R., Hendy, C., Kim, J.-N., Ishoey, T., et al. (2020) · Nutrients · doi:10.3390/nu12072041 · Cited by 159
“In terms of clinical outcomes, the restoration of the diversity and abundance of SCFA-producing bacteria has been associated with improved HbA1c levels in participants with T2DM [19].”
BackgroundSelf-citationZheng, H. J., Guo, J., Jia, Q., Huang, Y. S., Huang, W.-J., Zhang, W., Zhang, F., Liu, W. J., & Wang, Y. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.02.016 · Cited by 139
Self-citationShah, B. R., Li, B., Sabbah, H. A., Xu, W., & Mráz, J. (2020) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2020.06.010 · Cited by 157
“These claims were further backed by the results stating a significant reduction in butyrate-producing bacteria in feces of individuals suffering from ulcerative colitis and colon cancers in comparison to the healthy subjects (Sivaprakasam et al., 2016; L.; Zhao et al., 2018).”
ResultA guide to human microbiome research: study design, sample collection, and bioinformatics analysis
Qian, X., Chen, T., Xu, Y., Chen, L., Fu-xiang, S., Lu, M., & Liu, Y. (2020) · Chinese Medical Journal · doi:10.1097/cm9.0000000000000871 · Cited by 166
Self-citationPascale, N., Gu, F., Larsen, N., Jespersen, L., & Respondek, F. (2022) · Nutrients · doi:10.3390/nu14173629 · Cited by 157
“eligens was selectively increased by a high dietary fiber diet and negatively associated with postprandial glucose and insulin, body weight, and waist circumference [80].”
BackgroundLiu, T., Chen, X., Xu, Y., Wu, W., Tang, W., Chen, Z., Ji, G., Peng, J., Jiang, Q., Xiao, J., et al. (2019) · Environment International · doi:10.1016/j.envint.2019.05.076 · Cited by 150
Self-citationBalasubramanian, R., Schneider, E., Gunnigle, E., Cotter, P. D., & Cryan, J. F. (2024) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2024.105562 · Cited by 152
Evaluating microbiome-directed fibre snacks in gnotobiotic mice and humans
Delannoy-Bruno, O., Desai, C., Raman, A. S., Chen, R. Y., Hibberd, M. C., Cheng, J., Han, N., Castillo, J. J., Couture, G., Lebrilla, C. B., et al. (2021) · Nature · doi:10.1038/s41586-021-03671-4 · Cited by 142
Core Gut Bacteria Analysis of Healthy Mice
Wang, J., Lang, T., Shen, J., Dai, J., Tian, L., & Wang, X. (2019) · Frontiers in Microbiology · doi:10.3389/fmicb.2019.00887 · Cited by 136
Self-citationSalamone, D., Rivellese, A. A., & Vetrani, C. (2021) · Acta Diabetologica · doi:10.1007/s00592-021-01727-5 · Cited by 152
“9 g) has shown to increase faecal butyrate concentrations that associated with the reduction in fasting glucose and HbA1c concentrations [23].”
BackgroundDsouza, M., Menon, R., Crossette, E. M., Bhattarai, S. K., Schneider, J., Kim, Y., Reddy, S., Caballero, S., Felix, C. R., Cornacchione, L. P., et al. (2022) · Cell Host & Microbe · doi:10.1016/j.chom.2022.03.016 · Cited by 150
Ecological dynamics of the gut microbiome in response to dietary fiber
Liu, H., Liao, C., Wu, L. H., Tang, J., Chen, J., Lei, C., Zheng, L., Zhang, C., Liu, Y., Xavier, J. B., et al. (2022) · The ISME Journal · doi:10.1038/s41396-022-01253-4 · Cited by 153
“Dietary fibers can selectively enrich beneficial gut bacteria [6] and could be administered as “prebiotic” therapies to restore intestinal gut microbiota and elevate SCFA levels [7, 8].”
BackgroundSelf-citationMicrobiota-derived acetate enhances host antiviral response via NLRP3
Niu, J., Cui, M., Yang, X., Li, J., Yao, Y., Guo, Q., Lu, A., Qi, X., Zhou, D., Zhang, C., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-36323-4 · Cited by 154
Self-citationQu, Z., Liu, H., Ji, Y., Zheng, L., Huang, J., Wang, Z., Xie, C., Zuo, W., Xia, X., Sun, L., et al. (2025) · Nature Communications · doi:10.1038/s41467-025-55845-7 · Cited by 159
“Manipulating the gut microbiome with polysaccharides is a promising therapeutic strategy for various human diseases 53 – 55 .”
Self-citationYan, J., Xia, D., Zhou, W., Li, Y., Xiong, P., Li, Q., Wang, P., Li, M., Zheng, Y., & Cheng, Y. (2020) · Acta Biomaterialia · doi:10.1016/j.actbio.2020.07.062 · Cited by 142
Xu, L., Zhang, Y., Li, X., Li, C., Hu, H., Hu, J., Liu, M., Yang, Q. Z., Gu, P., Li, J., et al. (2025) · iMeta · doi:10.1002/imt2.270 · Cited by 154
Self-citationFragiadakis, G. K., Wastyk, H. C., Robinson, J. L., Sonnenburg, E. D., Sonnenburg, J. L., & Gardner, C. D. (2020) · The American Journal of Clinical Nutrition · doi:10.1093/ajcn/nqaa046 · Cited by 138
Metadata
- Authors
- Zhao, L., Zhang, F., Ding, X., Wu, G., Lam, Y. Y., Wang, X., Fu, H., Xue, X., Lu, C., Ma, J., Yu, L., Xu, C., Ren, Z., Xu, Y., Xu, S., Shen, H., Zhu, X., Shi, Y., Shen, Q., Dong, W., Liu, R., Ling, Y., Zeng, Y., Wang, X., Zhang, Q., Wang, J., Wang, L., Wu, Y., Zeng, B., Wei, H., Zhang, M., Peng, Y., & Zhang, C.
- Affiliations
- Rutgers, The State University of New Jersey (US)
- Shanghai Jiao Tong University (CN)
- Sijing Community Health Service Center of Songjiang District, Shanghai 201601, China.
- Sijing Hospital of Songjiang District, Shanghai 201601, China.
- Department of Endocrinology and Metabolism, Qidong People’s Hospital, Jiangsu 226200, China.
- Army Medical University (CN)
- Corresponding author
- Zhao, Liping
- Zhang, Feng
- Ding, Xiaoying
- Wu, Guojun
- Lam, Yan Y.
- Peng, Yongde
- Zhang, Chenhong
- ORCID
- Venue
- Science
- Published
- 2018-03-09
- Volume
- 359
- Issue
- 6380
- Pages
- 1151-1156
- ISSN
- 0036-8075 (ISSN-L)
- 1095-9203
- OpenAlex
- W2789495752
- Cited by
- 2,304
- References
- 63
- Citations by year
- 2026: 208 · 2025: 286 · 2024: 270 · 2023: 301 · 2022: 347 · 2021: 307 · 2020: 285 · 2019: 216 · 2018: 81
- FWCI
- 79.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Science (publishedVersion)
- PubMed (publishedVersion)
- Funders
- National Natural Science Foundation of China (31330005, 81401141, 81370904)
- Science and Technology Commission of Shanghai Municipality (14YF1402200)
- Key Projects of Shanghai Municipal Health Bureau Research Fund (201440033)
- Shanghai Jiao Tong University Research Funding on Medical and Engineering Interdisciplinary Projects (YG2015ZD08)
- Songjiang District Health Bureau of Climbing Medical Program (0702N14003)
- Shanghai Shen Kang Hospital Development Center for chronic disease prevention and control project (SHDC12015304)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Nursing › Nutrition and Dietetics › Microbial Metabolites in Food Biotechnology
- Health Sciences › Medicine › Gastroenterology › Gastrointestinal motility and disorders
- Keywords
- type 2 diabetes, gut microbiota, dietary fiber, short-chain fatty acids, SCFA-producing bacteria, fecal microbiota transplantation, glucagon-like peptide-1, HbA1c, indole, hydrogen sulfide, carbohydrate fermentation, isocaloric diet
- MeSH terms
- Gastrointestinal Microbiome, Adult, Aged, Bacteria, China, Diabetes Mellitus, Type 2, Diet, Dietary Fiber, Fatty Acids, Volatile, Feces, Female, Fermentation, Glycated Hemoglobin, Humans, Hydrogen Sulfide, Indoles, Male, Middle Aged, Glucagon-Like Peptide 1, Metagenomics
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.